Identification of the Candida albicans Cap1p Regulon

ABSTRACT Cap1p, a transcription factor of the basic region leucine zipper family, regulates the oxidative stress response (OSR) in Candida albicans. Alteration of its C-terminal cysteine-rich domain (CRD) results in Cap1p nuclear retention and transcriptional activation. To better understand the function of Cap1p in C. albicans, we used genome-wide location profiling (chromatin immunoprecipitation-on-chip) to identify its transcriptional targets in vivo. A triple-hemagglutinin (HA3) epitope was introduced at the C terminus of wild-type Cap1p (Cap1p-HA3) or hyperactive Cap1p with an altered CRD (Cap1p-CSE-HA3). Location profiling using whole-genome oligonucleotide tiling microarrays identified 89 targets bound by Cap1p-HA3 or Cap1p-CSE-HA3 (the binding ratio was at least twofold; P ≤ 0.01). Strikingly, Cap1p binding was detected not only at the promoter region of its target genes but also at their 3′ ends and within their open reading frames, suggesting that Cap1p may associate with the transcriptional or chromatin remodeling machinery to exert its activity. Overrepresented functional groups of the Cap1p targets (P ≤ 0.02) included 11 genes involved in the OSR (CAP1, GLR1, TRX1, SOD1, CAT1, and others), 13 genes involved in response to drugs (PDR16, MDR1, FLU1, YCF1, FCR1, and others), 4 genes involved in phospholipid transport (PDR16, GIT1, RTA2, and orf19.932), and 3 genes involved in the regulation of nitrogen utilization (GST3, orf19.2693, and orf19.3121), suggesting that Cap1p has other cellular functions in addition to the OSR. Bioinformatic analyses of the bound sequences suggest that Cap1p recognizes the DNA motif 5′-MTKASTMA. Finally, transcriptome analyses showed that increased expression generally accompanies Cap1p binding at its targets, indicating that Cap1p functions as a transcriptional activator.

[1]  G. Bellí,et al.  Redox control and oxidative stress in yeast cells. , 2008, Biochimica et biophysica acta.

[2]  Yuan-Ying Jiang,et al.  RTA2, a novel gene involved in azole resistance in Candida albicans. , 2008, Biochemical and biophysical research communications.

[3]  J. Morschhäuser,et al.  Mutations in the multi‐drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole‐resistant Candida albicans strains , 2008, Molecular microbiology.

[4]  R. Homayouni,et al.  A Gain-of-Function Mutation in the Transcription Factor Upc2p Causes Upregulation of Ergosterol Biosynthesis Genes and Increased Fluconazole Resistance in a Clinical Candida albicans Isolate , 2008, Eukaryotic Cell.

[5]  S. K. Balakrishnan,et al.  The tumor suppressor p53 associates with gene coding regions and co-traverses with elongating RNA polymerase II in an in vivo model , 2008, Oncogene.

[6]  F. Robert,et al.  Genomewide Location Analysis of Candida albicans Upc2p, a Regulator of Sterol Metabolism and Azole Drug Resistance , 2008, Eukaryotic Cell.

[7]  R. Homayouni,et al.  The Transcription Factor Mrr1p Controls Expression of the MDR1 Efflux Pump and Mediates Multidrug Resistance in Candida albicans , 2007, PLoS pathogens.

[8]  Sadri Znaidi,et al.  The zinc cluster transcription factor Tac1p regulates PDR16 expression in Candida albicans , 2007, Molecular microbiology.

[9]  R. Homayouni,et al.  Genome-Wide Expression and Location Analyses of the Candida albicans Tac1p Regulon , 2007, Eukaryotic Cell.

[10]  D. Diogo,et al.  Genotypic Evolution of Azole Resistance Mechanisms in Sequential Candida albicans Isolates , 2007, Eukaryotic Cell.

[11]  R. H. Gross,et al.  A novel ensemble learning method for de novo computational identification of DNA binding sites , 2007, BMC Bioinformatics.

[12]  M. Molin,et al.  Ionizing radiation induces a Yap1-dependent peroxide stress response in yeast. , 2007, Free radical biology & medicine.

[13]  Peter J. Park,et al.  Normalization and experimental design for ChIP-chip data , 2007, BMC Bioinformatics.

[14]  Hugo Y. K. Lam,et al.  Tilescope: online analysis pipeline for high-density tiling microarray data , 2007, Genome Biology.

[15]  Robert H. Gross,et al.  SCOPE: a web server for practical de novo motif discovery , 2007, Nucleic Acids Res..

[16]  S. Engelmann,et al.  Proteomic analysis of the oxidative stress response in Candida albicans , 2007, Proteomics.

[17]  D. Sanglard,et al.  Identification of promoter elements responsible for the regulation of MDR1 from Candida albicans, a major facilitator transporter involved in azole resistance. , 2006, Microbiology.

[18]  C. Kumamoto,et al.  Transcriptional Regulation of MDR1, Encoding a Drug Efflux Determinant, in Fluconazole-Resistant Candida albicans Strains through an Mcm1p Binding Site , 2006, Eukaryotic Cell.

[19]  Clifford A. Meyer,et al.  Genome-wide analysis of estrogen receptor binding sites , 2006, Nature Genetics.

[20]  B. Turcotte,et al.  A Fungal Family of Transcriptional Regulators: the Zinc Cluster Proteins , 2006, Microbiology and Molecular Biology Reviews.

[21]  Michael R. Seringhaus,et al.  TOS9 Regulates White-Opaque Switching in Candidaalbicans , 2006, Eukaryotic Cell.

[22]  Lin Tang,et al.  Inferring direct regulatory targets from expression and genome location analyses: a comparison of transcription factor deletion and overexpression , 2006, BMC Genomics.

[23]  Charles Boone,et al.  Identifying transcription factor functions and targets by phenotypic activation , 2006, Proceedings of the National Academy of Sciences.

[24]  J. Morschhäuser,et al.  Multiple cis-Acting Sequences Mediate Upregulation of the MDR1 Efflux Pump in a Fluconazole-Resistant Clinical Candida albicans Isolate , 2006, Antimicrobial Agents and Chemotherapy.

[25]  L. A. Stargell,et al.  TFIIA Plays a Role in the Response to Oxidative Stress , 2006, Eukaryotic Cell.

[26]  M. Raymond,et al.  PDR16‐mediated azole resistance in Candida albicans , 2006, Molecular microbiology.

[27]  J. Latgé,et al.  Signalling and oxidant adaptation in Candida albicans and Aspergillus fumigatus , 2006, Nature Reviews Microbiology.

[28]  J. Berman,et al.  A Mutation in Tac1p, a Transcription Factor Regulating CDR1 and CDR2, Is Coupled With Loss of Heterozygosity at Chromosome 5 to Mediate Antifungal Resistance in Candida albicans , 2006, Genetics.

[29]  K. Ying,et al.  Cap1p is involved in multiple pathways of oxidative stress response in Candida albicans. , 2006, Free radical biology & medicine.

[30]  T. Hughes,et al.  Mapping pathways and phenotypes by systematic gene overexpression. , 2006, Molecular cell.

[31]  Brice Enjalbert,et al.  Role of the Hog1 stress-activated protein kinase in the global transcriptional response to stress in the fungal pathogen Candida albicans. , 2005, Molecular biology of the cell.

[32]  C. Bustamante Treatment of Candida infection: a view from the trenches! , 2005, Current opinion in infectious diseases.

[33]  T. C. White,et al.  Drug-Induced Regulation of the MDR1 Promoter in Candida albicans , 2005, Antimicrobial Agents and Chemotherapy.

[34]  R. Akins An update on antifungal targets and mechanisms of resistance in Candida albicans. , 2005, Medical mycology.

[35]  B. Akache,et al.  Candida albicans Zinc Cluster Protein Upc2p Confers Resistance to Antifungal Drugs and Is an Activator of Ergosterol Biosynthetic Genes , 2005, Antimicrobial Agents and Chemotherapy.

[36]  F. Klis,et al.  Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood , 2005, Molecular microbiology.

[37]  F. Devaux,et al.  Early Expression of Yeast Genes Affected by Chemical Stress , 2005, Molecular and Cellular Biology.

[38]  D. Sanglard,et al.  TAC1, Transcriptional Activator of CDR Genes, Is a New Transcription Factor Involved in the Regulation of Candida albicans ABC Transporters CDR1 and CDR2 , 2004, Eukaryotic Cell.

[39]  Yoshiharu Inoue,et al.  Activity of the Yap1 Transcription Factor in Saccharomyces cerevisiae Is Modulated by Methylglyoxal, a Metabolite Derived from Glycolysis , 2004, Molecular and Cellular Biology.

[40]  P. Jolicoeur,et al.  Immunopathogenesis of Oropharyngeal Candidiasis in Human Immunodeficiency Virus Infection , 2004, Clinical Microbiology Reviews.

[41]  G. Goldman,et al.  Evaluation of fluconazole resistance mechanisms in candida albicans clinical isolates from HIV-infected patients in Brazil. , 2004, Diagnostic microbiology and infectious disease.

[42]  Alix T. Coste,et al.  Comparison of Gene Expression Profiles of Candida albicans Azole-Resistant Clinical Isolates and Laboratory Strains Exposed to Drugs Inducing Multidrug Transporters , 2004, Antimicrobial Agents and Chemotherapy.

[43]  J. Lieb,et al.  ChIP-chip: considerations for the design, analysis, and application of genome-wide chromatin immunoprecipitation experiments. , 2004, Genomics.

[44]  J. Sobel,et al.  Guidelines for treatment of candidiasis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[45]  D. Pittet,et al.  Management of candidiasis Management of Candida species infections in critically ill patients , 2003 .

[46]  W. Scott Moye-Rowley,et al.  Regulation of the Transcriptional Response to Oxidative Stress in Fungi: Similarities and Differences , 2003, Eukaryotic Cell.

[47]  C. Nombela,et al.  The Hog1 Mitogen-Activated Protein Kinase Is Essential in the Oxidative Stress Response and Chlamydospore Formation in Candidaalbicans , 2003, Eukaryotic Cell.

[48]  M. Waters,et al.  A survey of EPA/OPP and open literature on selected pesticide chemicals. III. Mutagenicity and carcinogenicity of benomyl and carbendazim. , 2002, Mutation research.

[49]  J. Morschhäuser The genetic basis of fluconazole resistance development in Candida albicans. , 2002, Biochimica et biophysica acta.

[50]  S. Kelly,et al.  Molecular basis of resistance to azole antifungals. , 2002, Trends in molecular medicine.

[51]  D. Sanglard,et al.  Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. , 2002, The Lancet. Infectious diseases.

[52]  Yoshiharu Inoue,et al.  Regulation of the Yeast Yap1p Nuclear Export Signal Is Mediated by Redox Signal-Induced Reversible Disulfide Bond Formation , 2001, Molecular and Cellular Biology.

[53]  M. Raymond,et al.  Multiple Yap1p-binding Sites Mediate Induction of the Yeast Major Facilitator FLR1 Gene in Response to Drugs, Oxidants, and Alkylating Agents* , 2001, The Journal of Biological Chemistry.

[54]  D. Sanglard,et al.  A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. , 2000, Microbiology.

[55]  J. Morschhäuser,et al.  Targeted gene disruption in Candida albicans wild‐type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates , 2000, Molecular microbiology.

[56]  D. Sanglard,et al.  Analysis of the oxidative stress regulation of the Candida albicans transcription factor, Cap1p , 2000, Molecular microbiology.

[57]  P. Sudbery,et al.  The MET3 promoter: a new tool for Candida albicans molecular genetics , 1999, Molecular microbiology.

[58]  M. Waters,et al.  A survey of EPA/OPP and open literature on selected pesticide chemicals. II. Mutagenicity and carcinogenicity of selected chloroacetanilides and related compounds. , 1999, Mutation research.

[59]  M. Raymond,et al.  The bZip Transcription Factor Cap1p Is Involved in Multidrug Resistance and Oxidative Stress Response inCandida albicans , 1999, Journal of bacteriology.

[60]  L H Lee,et al.  Crm1p mediates regulated nuclear export of a yeast AP‐1‐like transcription factor , 1998, The EMBO journal.

[61]  T. Toda,et al.  Crm1 (XpoI) dependent nuclear export of the budding yeast transcription factor yAP‐1 is sensitive to oxidative stress , 1998, Genes to cells : devoted to molecular & cellular mechanisms.

[62]  M. Raymond,et al.  AP1-mediated Multidrug Resistance in Saccharomyces cerevisiae Requires FLR1 Encoding a Transporter of the Major Facilitator Superfamily* , 1997, The Journal of Biological Chemistry.

[63]  N Jones,et al.  Regulation of yAP‐1 nuclear localization in response to oxidative stress , 1997, The EMBO journal.

[64]  J. Wemmie,et al.  The Saccharomyces cerevisiae AP-1 Protein Discriminates between Oxidative Stress Elicited by the Oxidants H2O2 and Diamide* , 1997, The Journal of Biological Chemistry.

[65]  A. Futcher,et al.  Use of polymerase chain reaction epitope tagging for protein tagging in Saccharomyces cerevisiae , 1995, Yeast.

[66]  D. Irwin,et al.  Isogenic strain construction and gene mapping in Candida albicans. , 1993, Genetics.

[67]  Ellson Y. Chen,et al.  Overview of manual and automated DNA sequencing by the dideoxy chain termination method , 1991 .

[68]  T. A. Brown,et al.  A rapid and simple method for preparation of RNA from Saccharomyces cerevisiae. , 1990, Nucleic acids research.

[69]  S. Miller,et al.  Directed mutagenesis in Candida albicans: one-step gene disruption to isolate ura3 mutants , 1987, Molecular and cellular biology.

[70]  K. Ying,et al.  Cap1p plays regulation roles in redox, energy metabolism and substance transport: an investigation on Candida albicans under normal culture condition. , 2007, Frontiers in bioscience : a journal and virtual library.

[71]  D. Pittet,et al.  Management of Candida species infections in critically ill patients. , 2003, The Lancet. Infectious diseases.

[72]  F. Sherman Getting started with yeast. , 1991, Methods in enzymology.

[73]  Gerald R. Fink,et al.  Methods in Yeast Genetics: A Laboratory Course Manual , 1987 .